• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

UCLA’s Dr. David Feinberg Appointed New Geisinger CEO

by HITC Staff 02/24/2015 1 Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Dr. David T. Feinberg
Dr. David T. Feinberg

 

UCLA president David T. Feinberg, M.D., M.B.A has been named the new president and chief executive officer of Geisinger Health System, effective May 1, 2015. Dr. Feinberg, who is succeeding Glenn Steele, Jr., M.D., Ph.D., will become only the sixth chief executive officer in Geisinger’s 100-year history.

During his tenure at UCLA, Feinberg focused on high quality clinical standards for patient care, safety and satisfaction, and the UCLA Health System hospitals have regularly ranked among the best in the United States by U.S. News and World Report.

“I am honored to become part of the Geisinger family,” said Dr. Feinberg in a statement. “I have always been impressed with Geisinger’s commitment to doing what is right and best for its patients and members, as well as its many contributions to improving care and reforming our nation’s health care system. It is important to me to not only continue, but also expand Geisinger’s work in patient care, research, education, innovation and community service, and I look forward to continuing Geisinger’s trajectory of achievement upward.”

Feinberg Background

Named to the 50 Most Influential Physician Executives and Leaders by Modern Healthcare, Feinberg has had a long, successful career at UCLA. In addition to his president, CEO and associate vice chancellor roles, he has also served as vice chair for clinical affairs, Department of Psychiatry and Behavioral Sciences; Medical Director, Resnick Neuropsychiatric Hospital at UCLA; medical director, UCLA Neuropsychiatric & Behavioral Health Sciences; medical director of managed care/outpatient services, medical director/adolescent partial hospitalization program, founder and director of child and adolescent consultation, diagnosis and brief treatment program and director, training for child and adolescent fellow substance abuse rotation, UCLA Neuropsychiatric Institute and Hospital.

Additionally, Dr. Steele will continue as Chairman of xG Health Solutions, an independently operated venture based in Columbia, Maryland, that helps health care organizations across the country create value and improve quality. Geisinger Health System is one of the nation’s largest integrated, physician-led rural health services organizations serving more than three million residents throughout 48 counties in central, south-central and northeast Pennsylvania.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |